Chimeric Antigen Receptor T cells for B Cell Neoplasms: Choose the Right CAR for You
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,Hematology
Link
http://link.springer.com/content/pdf/10.1007/s11899-016-0336-z.pdf
Reference134 articles.
1. Ruella M, Gill S. How to train your T cell: genetically engineered chimeric antigen receptor T cells versus bispecific T-cell engagers to target CD19 in B acute lymphoblastic leukemia. Expert opinion on biological therapy. 2015;15(6):761–6. doi: 10.1517/14712598.2015.1009888 .
2. June CH, Maus MV, Plesa G, Johnson LA, Zhao Y, Levine BL, et al. Engineered T cells for cancer therapy. Cancer immunology, immunotherapy : CII. 2014;63(9):969–75. doi: 10.1007/s00262-014-1568-1 .
3. Barbee MS, Ogunniyi A, Horvat TZ, Dang TO. Current status and future directions of the immune checkpoint inhibitors ipilimumab, pembrolizumab, and nivolumab in oncology. The Annals of pharmacotherapy. 2015;49(8):907–37. doi: 10.1177/1060028015586218 .
4. Maude S, Barrett DM. Current status of chimeric antigen receptor therapy for haematological malignancies. British journal of haematology. 2016;172(1):11–22. doi: 10.1111/bjh.13792 .
5. Ruella M, Kalos M. Adoptive immunotherapy for cancer. Immunological reviews. 2014;257(1):14–38. doi: 10.1111/imr.12136 .
Cited by 61 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Cellular Therapy with Engineered T Cells, Efficacy, and Side Effects: Gene Editing/Gene Therapy;The EBMT Handbook;2024
2. Advancing the frontiers of adaptive cell therapy: A transformative mechanistic journey from preclinical to clinical settings;International Immunopharmacology;2023-12
3. CAR-NK Cells Generated with mRNA-LNPs Kill Tumor Target Cells In Vitro and In Vivo;International Journal of Molecular Sciences;2023-08-29
4. Anti-ROR1 CAR-T cells: Architecture and performance;Frontiers in Medicine;2023-02-17
5. CAR-T Engager proteins optimize anti-CD19 CAR-T cell therapies for lymphoma;OncoImmunology;2022-08-17
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3